ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Translational Session

Let Them Flow: Cell-Based Therapies in Kidney Transplantation

November 08, 2019 | 02:00 PM - 04:00 PM

Location: 151, Walter E. Washington Convention Center

Session Description

Cell-based therapies, including the use of donor-derived and "off-the-shelf" T cells, are an exciting new approach for inducing tolerance and treating rejection, viral infections, and cancer. This session reviews current applications in the clinical setting.

Learning Objective(s)

  • Describe the range of application of cell-based therapies in transplantation, including tolerance induction and treatment of rejection, cancer, and viral infections
  • Discuss the different approaches to using T regulatory cells in tolerance induction
  • Explain how T cells can be modified to target specific antigens
  • Describe the difference between donor-derived and off-the-shelf T-cell therapies
  • Understand the rationale for use of T regulatory cells to treat sub-clinical rejection

Learning Pathway(s)

  • Transplantation/Immunology


  • Vineeta Kumar, MD
  • Jonathan S. Maltzman, MD, PhD


  • What We Learned from the ONE Study and Where Do We Go from Here
    02:00 PM - 02:30 PM
    Edward K. Geissler, PhD
  • Chimeric Antigen Receptor (CAR) T Cells in Transplantation
    02:30 PM - 03:00 PM
    Caroline Lamarche, MD
  • Cell-Based Therapies to Target Viral Infections and Cancer After Transplantation
    03:00 PM - 03:30 PM
    Susan E. Prockop, MD
  • Promoting Tolerance with Regulatory Dendritic Cells
    03:30 PM - 04:00 PM
    Diana Metes, MD